The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of SRA737 (formerly known as CCT245737) administered orally in patients with advanced cancer.
 
Maxime Chenard-Poirier
No Relationships to Disclose
 
Alvaro Henrique Ingles Garces
No Relationships to Disclose
 
Robert Hugh Jones
Consulting or Advisory Role - Orion
 
Amy Quinton
Honoraria - Celgene
 
Elizabeth R. Plummer
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - Astex Pharmaceuticals; AstraZeneca; Bayer; Clovis Oncology; Karus Therapeutics; Mission Therapeutics; MSD Oncology; Novartis; Pierre Fabre; Roche/Genentech; Vertex
Speakers' Bureau - Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Clovis Oncology (Inst); Eisai (Inst); Etherapeutics (Inst); Ipsen (Inst); vertex (Inst)
Patents, Royalties, Other Intellectual Property - Named on patent of use of PARP inhibitor rucaparib (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Yvette Drew
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Clovis Oncology
Speakers' Bureau - AstraZeneca
Research Funding - Clovis Oncology (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Clovis Oncology
 
Mark Marion Kowalski
Employment - Arbutus Biopharma; Sierra Oncology
Leadership - Arbutus Biopharma; Sierra Oncology
Consulting or Advisory Role - Arbutus Biopharma
Travel, Accommodations, Expenses - Arbutus Biopharma; Sierra Oncology
 
Barbara J. Klencke
Employment - Sierra Oncology
Leadership - Sierra Oncology
Stock and Other Ownership Interests - Abbvie; Agenus; Amgen; Bristol-Myers Squibb; Celgene; Exelixis; Fidelity Investments; Merck; Pfizer; Portola Pharmaceuticals; Sierra Oncology; Vertex
 
Udai Banerji
Employment - Institute of Cancer Research
Consulting or Advisory Role - Astex Pharmaceuticals; Novartis
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Onyx (Inst)